Factor XIII Prevents Development of Myocardial Edema in Children Undergoing Surgery for Congenital Heart Disease
Authors:
- 1 June 2001
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 936 (1) , 617-620
Abstract
In a prospective investigation of perioperative cardiac edema formation requiring a delayed sternal closure, we identified thrombin increase combined with a simultaneous decrease of factor XIII as a probable cause. After experimental studies additionally revealed that factor XIII could protect endothelial barrier function, we did another prospective randomized trial in which factor XIII or placebo was preoperatively substituted. The substitution finally showed distinct effects minimizing the incidence of myocardial swelling. Therefore, the clinical application of factor XIII may have a valuable therapeutic benefit in cases of leakage syndrome during extracorporeal circulation in congenital heart surgery.Keywords
This publication has 6 references indexed in Scilit:
- Effect of Factor XIII on Endothelial Barrier FunctionJournal of Experimental Medicine, 1999
- Outcomes After Delayed Sternal Closure in Pediatric Heart Operations: A 10-Year ExperienceThe Annals of Thoracic Surgery, 1997
- Regulation of Thrombin-Mediated Endothelial Cell Contraction and PermeabilitySeminars in Thrombosis and Hemostasis, 1996
- Cardiac surgical conditions induced by β-blockade: Effect on myocardial fluid balanceThe Annals of Thoracic Surgery, 1996
- Myocardial edema, left ventricular function, and pulmonary hypertensionJournal of Applied Physiology, 1995
- Perioperative monitoring of total body water by bio-electrical impedance in children undergoing open heart surgeryEuropean Journal of Cardio-Thoracic Surgery, 1991